Human IL-13 R alpha 1 Antibody AF152 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemHuman IL-13 R alpha 1 Antibody
CompanyR&D Systems, a Bio-Techne Brand
Price $519.00Supplier Page View Company Product Page
Catalog NumberAF152
ApplicationsFlow Cytometry,Immunohistochemistry,Western Blot,Immunohistochemistry-Paraffin,Immunohistochemistry-Frozen,Neutralization,CyTOF-ready
Conjugate/TagUnconjugated
IsotypeIgG
FormatLyophilized from a 0.2 µm filtered solution in PBS with Trehalose. See Certificate of Analysis for details. *Small pack size (-SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS
ReactivityHuman
Quantity100 ug (also 25 ug)
TargetIL-13 R alpha 1
HostGoat
ClonalityPolyclonal
ImmunogenMouse myeloma cell line NS0-derived recombinant human IL-13 R alpha 1, Ala27-Thr343 (Thr130Ile), Accession # Q5JSL4
ConcentrationLYOPH
PurityAntigen Affinity-purified
Antibody TypePrimary Antibodies
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution
NCBI Full Gene Nameinterleukin 13 receptor subunit alpha 1
NCBI Gene AliasesCD213A1, CT19, IL-13Ra, NR4

Specifications/Features

Available conjugates: Unconjugated

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Inclusion of 4-1BB Costimulation Enhances Selectivity and Functionality of IL13Rα2-Targeted Chimeric Antigen Receptor T CellsCancer Res CommunJanuary 1, 2023Starr R, Aguilar B, Gumber D, Maker M, Huard S, Wang D, Chang WC, Brito A, Chiu V, Ostberg JR, et al.for human IL13Rα1 and IL13Rα2 was performed with R&D Systems goat polyclonal reagents catalog nos. AF152 and AF146, respectively, with phycoerythrin-conjugated donkey anti-goat secondary antibody (Novus Biologicals,

(2) The IL-4/IL-13 signaling axis promotes prostatic fibrosisPloS oneJanuary 1, 2022D'Arcy Q, Gharaee-Kermani M, Zhilin-Roth A, Macoska JA.tissues were sectioned at five-micron thickness and labeled with IL-4Rα (MAB230, R&D Systems), IL-13Rα1 (AF152, R&D Systems), or IL-13Rα2 (AF146, R&D Systems) antibodies (1:100) using AEC solution and N-Histofine

(3) Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against GlioblastomaMolecular therapy : the journal of the American Society of Gene TherapyJanuary 3, 2018Brown CE, Aguilar B, Starr R, Yang X, Chang WC, Weng L, Chang B, Sarkissian A, Brito A, Sanchez JF, et al.

(4) Expression of surfactant protein D in airways of asthmatics and interleukin-13 modulation of surfactant protein D in human models of airway epitheliumRespiratory researchFebruary 15, 2015Xu J, Singhera GK, Dorscheid DR.

(5) IL-4 and IL-13 differentially regulate TLR-induced eosinophil-basophil differentiation of cord blood CD34+ progenitor cellsPloS oneJanuary 1, 2014Reece P, Gauvreau GM, Sehmi R, Denburg JA.

(6) Human osteoarthritic cartilage shows reduced in vivo expression of IL-4, a chondroprotective cytokine that differentially modulates IL-1β-stimulated production of chemokines and matrix-degrading enzymes in vitroPloS oneJanuary 1, 2014Assirelli E, Pulsatelli L, Dolzani P, Platano D, Olivotto E, Filardo G, Trisolino G, Facchini A, Borzì RM, Meliconi R.(mouse monoclonal MAB230, IgG2a R&D Systems) at a concentration of 10 µg/ml, to the IL-13Rα1 chain (Goat AF152 R&D Systems) at a concentration of 1 µg/ml and to a common gamma chain (Goat AF284 R&D Systems) at a

(7) The involvement of interleukin-1 and interleukin-4 in the response of human annulus fibrosus cells to cyclic tensile strain: an altered mechanotransduction pathway with degenerationArthritis research & therapyJanuary 28, 2011Gilbert HT, Hoyland JA, Freemont AJ, Millward-Sadler SJ.no. MAB284; R&D Systems, Abingdon, UK) or IL-13 receptor α1 (IL-13Rα1) (1:25 dilution, catalogue no. AF152; R&D Systems, Abingdon, UK). After being washed with Tris-buffered saline, samples were incubated at

(8) Obligatory role for interleukin-13 in obstructive lesion development in airway allograftsThe American journal of pathologyJuly 1, 2006Lama VN, Harada H, Badri LN, Flint A, Hogaboam CM, McKenzie A, Martinez FJ, Toews GB, Moore BB, Pinsky DJ.

(9) Classification of distinct subtypes of peripheral T-cell lymphoma unspecified, identified by chemokine and chemokine receptor expression: Analysis of prognosisInternational journal of oncologySeptember 1, 2004Ohshima K, Karube K, Kawano R, Tsuchiya T, Suefuji H, Yamaguchi T, Suzumiya J, Kikuchii M.

(10) Differential effect of IL-4 and IL-13 on the expression of recombination-activating genes in mature B cells from human peripheral bloodCellular immunologyFebruary 1, 2004Kajiwara K, Shinazawa M, Morishima H, Yanagihara Y.

(11) Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndromeThe American journal of pathologyApril 1, 2002Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, Alitalo K, Damsky C, Fisher SJ.